Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.290
+0.020 (1.57%)
At close: May 6, 2026, 4:00 PM EDT
1.280
-0.010 (-0.78%)
After-hours: May 6, 2026, 6:21 PM EDT
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $54.49 million as of May 6, 2026. Its market cap has decreased by -71.56% in one year.
Market Cap
54.49M
Enterprise Value
48.36M
1-Year Change
-71.56%
Ranking
Category
Stock Price
$1.29
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $54.49M, a decrease of -95.91%. That is a compound annual growth rate of -43.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 54.49M | -40.23% |
| Dec 31, 2025 | 91.16M | -66.00% |
| Dec 31, 2024 | 268.12M | -45.11% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phaos Technology Holdings (Cayman) Limited | 67.76M |
| LENSAR | 65.56M |
| Sensus Healthcare | 63.38M |
| Accuray | 56.42M |
| electroCore | 56.18M |
| InspireMD | 55.39M |
| Baird Medical Investment Holdings | 55.30M |
| Envoy Medical | 51.53M |